Literature DB >> 7340846

Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.

E G Afting, W Bernhardt, R W Janzen, H J Röthig.   

Abstract

The excretion of N tau-methylhistidine and creatinine was determined in a totally paralysed patient wih neither macroscopic nor microscopic detectable skeletal-muscle tissue. In this subject, it was possible for the first time to measure the basal non-skeletal-muscle-dependent excretion of N tau-methylhistidine and creatinine per 24 h and per kg of non-muscular body weight, 1.15 mumol (N tau-methylhistidine) and 35 mumol (creatinine) respectively. For the calculation of myofibrillar protein breakdown and skeletal-muscle mass on the basis of N tau-methylhistidine and creatinine excretion, the values have to be corrected for non-muscular sources. Our data show that skeletal-muscle tissue is the major contributor of N tau-methylhistidine in urine, since it contributes as much as 75% to the urinary excretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340846      PMCID: PMC1163557          DOI: 10.1042/bj2000449

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  The metabolism of methylhistidine compounds in animals.

Authors:  R W COWGILL; B FREEBURG
Journal:  Arch Biochem Biophys       Date:  1957-10       Impact factor: 4.013

2.  3-Methylhistidine, a new amino acid from human urine.

Authors:  H H TALLAN; W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1954-02       Impact factor: 5.157

3.  Protein synthesis in cultured muscle cells: methylation of nascent proteins.

Authors:  M Reporter
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

4.  Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative.

Authors:  V R Young; S D Alexis; B S Baliga; H N Munro; W Muecke
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

5.  Enzymatic methylation of skeletal muscle contractile proteins.

Authors:  B Krzysik; J P Vergnes; I McManus
Journal:  Arch Biochem Biophys       Date:  1971-09       Impact factor: 4.013

6.  Lack of in vitro binding of 3-methylhistidine to transfer RNA by aminoacyl ligases from skeletal muscle.

Authors:  V R Young; B S Baliga; S D Alexis; H N Munro
Journal:  Biochim Biophys Acta       Date:  1970-01-21

7.  3-methylhistidine, a component of actin.

Authors:  A M Asatoor; M D Armstrong
Journal:  Biochem Biophys Res Commun       Date:  1967-01-23       Impact factor: 3.575

Review 8.  Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.

Authors:  V R Young; H N Munro
Journal:  Fed Proc       Date:  1978-07

9.  Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N tau-methylhistidine.

Authors:  F M Tomas; H N Munro; V R Young
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

10.  3-methylhistidine in actin and other muscle proteins.

Authors:  P Johnson; C I Harris; S V Perry
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

View more
  4 in total

Review 1.  Protein intake and athletic performance.

Authors:  P W Lemon; D N Proctor
Journal:  Sports Med       Date:  1991-11       Impact factor: 11.136

2.  Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion.

Authors:  G Marchesini; G Forlani; M Zoli; P Vannini; E Pisi
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

3.  Analysis of reference interval and age-related changes in serum biochemistry and hematology in the specific pathogen free miniature pig.

Authors:  Su-Cheong Yeom; Seong-Yong Cho; Chung-Gyu Park; Wang-Jae Lee
Journal:  Lab Anim Res       Date:  2012-12-26

4.  Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.

Authors:  Sandrine Ellero-Simatos; Ewa Szymańska; Ton Rullmann; Wim Ha Dokter; Raymond Ramaker; Ruud Berger; Thijs Mp van Iersel; Age K Smilde; Thomas Hankemeier; Wynand Alkema
Journal:  Genome Med       Date:  2012-11-30       Impact factor: 11.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.